FAST NEWS: 111 Inc. enters strategic supply agreement with Scrianen Pharma
The Latest: Pharmaceutical distributor 111 Inc. (YI.US) announced Tuesday that it has entered into a strategic direct supply partnership with drug developer and maker Beijing Scrianen Pharmaceutical. Looking Up: This…
FAST NEWS: 111 Inc’s Revenue Flattens on Covid Disruptions
The Latest: Online drug seller 111 Inc. (YI.US) on Thursday reported third-quarter revenue of 3.35 billion yuan ($470.8 million), roughly the same as a year earlier. Its net loss for…
Share Buybacks Bring Mixed Results for Smart Share Global, Cloopen
Two China tech firms are the latest in a recent string to announce share repurchases with hopes of boosting their sagging stocks Key points: Smart Share Global’s shares surged after…
Solid Earnings, Modest Buyback Fail to Boost Drug Seller 111 Inc.
Profitability is now in focus at online drug company, as it seeks to breathe life into its shares that are down 10% this year Key takeaways: 111’s revenue grew 87%…
RECENT ARTICLES
-
Cancer drug maker Genfleet joins Hong Kong IPO influx
- Cloudbreak Pharma sets sights on Hong Kong IPO after license deal
- TCMTech fuses old with the new by mixing AI and Chinese medicine
-
Earnings blow for CSPC Pharma as the state drives a hard bargain
1093.HK
- Why aim small? 51World Digital Twin sets its sights on cloning Earth
-
Bumper dividend could trigger buyout for Ping An Health
1833.HK
